Rick E Winningham - Net Worth and Insider Trading
Rick E Winningham Net Worth
The estimated net worth of Rick E Winningham is at least $14 Million dollars as of 2024-11-13. Rick E Winningham is the CHIEF EXECUTIVE OFFICER of Theravance Biopharma Inc and owns about 1,443,364 shares of Theravance Biopharma Inc (TBPH) stock worth over $13 Million. Rick E Winningham is also the Director of Jazz Pharmaceuticals PLC and owns about 10,444 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $1 Million. Details can be seen in Rick E Winningham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rick E Winningham has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rick E Winningham
Rick E Winningham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rick E Winningham owns 4 companies in total, including Theravance Biopharma Inc (TBPH) , Jazz Pharmaceuticals PLC (JAZZ) , and OncoMed Pharmaceuticals Inc (OMED) among others .
Click here to see the complete history of Rick E Winningham’s form 4 insider trades.
Insider Ownership Summary of Rick E Winningham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2022-12-14 | director & Chief Executive Officer |
| JAZZ | Jazz Pharmaceuticals PLC | 2023-08-14 | director |
| OMED | OncoMed Pharmaceuticals Inc | 2018-06-22 | director |
 | | 2004-10-04 | director & Chief Executive Officer |
Rick E Winningham Latest Holdings Summary
Rick E Winningham currently owns a total of 2 stocks. Among these stocks, Rick E Winningham owns 1,443,364 shares of Theravance Biopharma Inc (TBPH) as of December 14, 2022, with a value of $13 Million and a weighting of 90.6%. Rick E Winningham also owns 10,444 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 14, 2023, with a value of $1 Million and a weighting of 9.4%.
Latest Holdings of Rick E Winningham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2022-12-14 | 1,443,364 | 8.91 | 12,860,373 |
| JAZZ | Jazz Pharmaceuticals PLC | 2023-08-14 | 10,444 | 127.70 | 1,333,699 |
Holding Weightings of Rick E Winningham
Rick E Winningham Form 4 Trading Tracker
According to the SEC Form 4 filings, Rick E Winningham has made a total of 1 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Theravance Biopharma Inc is the sale of 50,000 shares on December 14, 2022, which brought Rick E Winningham around $559,500.
According to the SEC Form 4 filings, Rick E Winningham has made a total of 4 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,241 shares on August 14, 2023, which brought Rick E Winningham around $171,457.
Insider Trading History of Rick E Winningham
- 1
Rick E Winningham Trading Performance
GuruFocus tracks the stock performance after each of Rick E Winningham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rick E Winningham is 29.77%. GuruFocus also compares Rick E Winningham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rick E Winningham within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rick E Winningham's insider trading performs compared to the benchmark.
Performance of Rick E Winningham
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25 | | | | | |
| Relative Return to S&P 500(%) | 26.71 | | | | | |
Rick E Winningham Ownership Network
Ownership Network List of Rick E Winningham
Ownership Network Relation of Rick E Winningham
Rick E Winningham Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Rick E Winningham is the director & Chief Executive Officer of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Rick E Winningham made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 16,734 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 0 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,963 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,471,961 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Rick E Winningham Mailing Address
Above is the net worth, insider trading, and ownership report for Rick E Winningham. You might contact Rick E Winningham via mailing address: 901 Gateway Boulevard, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
